title: Oral bile acids in cystic fibrosis-associated liver disease.
authors.affiliation: Department of Paediatrics, University of Milan, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Colombo
authors.forename: A
authors.initials: A
authors.lastname: Crosignani
authors.forename: M G
authors.initials: MG
authors.lastname: Apostolo
authors.forename: M T
authors.initials: MT
authors.lastname: Marzano
authors.forename: N
authors.initials: N
authors.lastname: Bettinardi
authors.forename: A
authors.initials: A
authors.lastname: Giunta
mesh_terms: D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000150:complications*; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy*; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014580:Ursodeoxycholic Acid